Cardinal Health, Inc. CAH
277.45 USD +0.66 (+0.24%)
At closeNov 11, 2026, 4:41 PM EST
277.45 0.00 0.00%
After hours · Nov 11, 4:41 PM ET
274.74 Day range 277.76
182.50 52-week range 277.45
- YTD
- +35.01%
- 1 year
- +35.47%
News
prnewswire.com Cardinal Health Board of Directors Approves Quarterly Dividend DUBLIN, Ohio, Nov. 11, 2026 /PRNewswire/ -- Cardinal Health (NYSE: CAH) announced today that its Board of Directors approved its quarterly dividend of $0.5158 per share, out of the Company's capital…
zacks.com Here's Why Cardinal Health (CAH) is a Great Momentum Stock to Buy Does Cardinal Health (CAH) have what it takes to be a top stock pick for momentum investors? Let's find out.
benzinga.com If You Invested $100 In Cardinal Health Stock 5 Years Ago, You Would Have This Much Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 30.64% on an annualized basis producing an average annual return of 40.55%. Currently, Cardinal Health has a market…
zacks.com Cardinal (CAH) is an Incredible Growth Stock: 3 Reasons Why Cardinal (CAH) could produce exceptional returns because of its solid growth attributes.
zacks.com 4 Stocks with Impressive Interest Coverage Ratios to Buy Now Stride, Ralph Lauren, Cardinal Health and Vertiv stand out for strong interest coverage ratios, earnings growth prospects and financial resilience.
benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $286 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $260 to $286.
defenseworld.net CenterBook Partners LP Makes New Investment in Cardinal Health, Inc. $CAH CenterBook Partners LP bought a new position in Cardinal Health, Inc. (NYSE: CAH) during the third quarter, according to its most recent 13F filing with the SEC. The fund bought 4,979 shares of the…
benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $304 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $304.
zacks.com Are Medical Stocks Lagging Cardinal Health (CAH) This Year? Here is how Cardinal Health (CAH) and Addus HomeCare (ADUS) have performed compared to their sector so far this year.
zacks.com Should Value Investors Buy Cardinal Health (CAH) Stock? Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the…
benzinga.com Jim Cramer Praises The 'Number One Oil Company In The World' On CNBC's “Mad Money Lightning Round,” Jim Cramer praised VF Corp (NYSE:VFC) and expects the stock to rise. Supporting his choice, VF posted better-than-expected second-quarter earnings on Oct. 28.
seekingalpha.com 69 Dividend Champions Ranked By Quality Scores (November 2026) I present 69 Dividend Champions with Dividend Safety scores of 8+ and rank them using my 9F Quality Scores system. Twenty-two featured Dividend Champions are undervalued, while 21 are overvalued.…
marketbeat.com Cardinal Health Q1 Earnings Call Highlights Cardinal Health NYSE: CAH raised its fiscal 2027 earnings outlook after reporting double-digit profit growth in its pharmaceutical and specialty segment and its other growth businesses for the first…
benzinga.com RBC Capital Maintains Outperform on Cardinal Health, Raises Price Target to $295 RBC Capital analyst Ryan Halsted maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $276 to $295.
zacks.com CAH Q1 Earnings Call Highlights Raised Outlook and Specialty Growth Cardinal Health raises its fiscal 2027 earnings outlook as specialty growth, strong generics demand and customer renewals offset medical distribution pressures.
benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $320 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $270 to $320.
defenseworld.net Cardinal Health (NYSE:CAH) Hits New 12-Month High Following Earnings Beat Shares of Cardinal Health, Inc. (NYSE: CAH - Get Free Report) reached a new 52-week high during trading on Thursday following a better than expected earnings announcement. The company traded as high…
seekingalpha.com Cardinal Health, Inc. (CAH) Q1 2027 Earnings Call Transcript Cardinal Health, Inc. ( CAH ) Q1 2027 Earnings Call November 5, 2026 8:30 AM EST Company Participants David Frost - Vice President of Investor Relations Jason Hollar - CEO & Director Aaron Alt -…
zacks.com CAH Q1 Earnings & Revenues Beat Estimates on Pharma Strength Cardinal Health beats Q1 FY27 earnings and revenue estimates, fueled by pharmaceutical sales growth, and raises its full-year earnings outlook.
benzinga.com Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure Cardinal Health Inc. (NYSE:CAH ) shares jumped on Thursday after the company reported better-than-expected first-quarter 2027 earnings and issued an updated fiscal 2027 outlook.
benzinga.com Cardinal Health Sees Healthy Demand, Despite Modest Commodity Pressure Cardinal Health tops Q1 2027 estimates, and raises guidance, as robust pharma sales offset petroleum headwinds in medical distribution.
benzinga.com Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings U.S. stocks traded lower midway through trading, with the Nasdaq Composite falling around 4.5% on Thursday.
benzinga.com Nasdaq Tumbles 4.5%; Cardinal Health Shares Gain After Upbeat Q1 Earnings U.S. stocks tumbled: Nasdaq -4.5%, S&P 500 -3.3%, Dow -2.5%. Cardinal Health rose on strong results; AppLovin surged 32%, while Veracyte fell 55%.
zacks.com Compared to Estimates, Cardinal (CAH) Q1 Earnings: A Look at Key Metrics While the top- and bottom-line numbers for Cardinal (CAH) give a sense of how the business performed in the quarter ended September 2026, it could be worth looking at how some of its key metrics…
benzinga.com Cardinal Health Q1 2027 Earnings Call Transcript Cardinal Health (NYSE:CAH) reported first-quarter financial results on Thursday. The transcript from the company’s first-quarter earnings call has been provided below.This transcript is brought to…
zacks.com Cardinal Health (CAH) Q1 Earnings and Revenues Top Estimates Cardinal Health (CAH) came out with quarterly earnings of $3.26 per share, beating the Zacks Consensus Estimate of $2.92 per share. This compares to earnings of $2.55 per share a year ago.
benzinga.com Cardinal Health Q1 Adj. EPS $3.26 Beats $2.94 Estimate, Sales $67.513B Beat $66.588B Estimate Cardinal Health (NYSE:CAH) reported quarterly earnings of $3.26 per share which beat the analyst consensus estimate of $2.94 by 10.88 percent. This is a 27.84 percent increase over earnings of $2.55…- benzinga.com Cardinal Health Raises FY2027 Adj EPS Guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 Est Cardinal Health (NYSE:CAH) raises FY2027 Adj EPS guidance from $12.40-$12.60 to $12.80-$13.00 vs $12.56 analyst estimate..
prnewswire.com Cardinal Health Reports First Quarter Fiscal Year 2027 Results and Raises Outlook First quarter revenue increased 5% to $67.5 billion GAAP 1 operating earnings increased 13% to $753 million; GAAP diluted EPS increased 27% to $2.38 Non-GAAP operating earnings increased 17% to $1.0…
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q3 Earnings Cardinal Health, Inc. (NYSE:CAH) will release its first quarter earnings report before the opening bell on Thursday, Nov. 5.
benzinga.com Top Wall Street Forecasters Revamp Cardinal Health Expectations Ahead Of Q1 Earnings Cardinal Health expects Q1 EPS of $2.94 and revenue of $66.51B. Analysts remain bullish, raising price targets up to $295.
benzinga.com Dow Jumps Over 1,500 Points After Midterms: Investor Sentiment Improves, Greed Index Moves To ‘Fear’ Zone CNN Fear & Greed rose to 27 in the Fear zone as U.S. stocks surged after Democrats won Congress; oil fell and most sectors gained.
benzinga.com Qualcomm, US Foods And 3 Stocks To Watch Heading Into Thursday Stocks in focus: Cardinal Health and US Foods report earnings; Qualcomm and Snap shares fall after results; Airbnb reports after the close.
benzinga.com Here's How Much $1000 Invested In Cardinal Health 5 Years Ago Would Be Worth Today Cardinal Health (NYSE:CAH) has outperformed the market over the past 5 years by 29.24% on an annualized basis producing an average annual return of 39.65%. Currently, Cardinal Health has a market…
benzinga.com Toyota, ConocoPhillips On Deck Thursday As Auto Demand, Oil Prices Face Test Toyota Motor headlines Thursday’s reports, with investors weighing the automaker’s earnings outlook against a stock still well below its 52-week high. ConocoPhillips, Sony Group, Parker Hannifin and…- benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $286 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $265 to $286.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $280 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $250 to $280.- benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $295 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $280 to $295.
benzinga.com 10 Health Care Stocks With Whale Alerts In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…
benzinga.com Cardinal Health, McKesson Double Down on CVS Deals Through 2032 Cardinal Health and McKesson extend drug distribution deals with CVS Health through June 2032, reaffirming FY2027 adjusted earnings guidance.- benzinga.com Cardinal Health Enters Into Binding LOI To Extend Existing Distribution Agreement With CVS Health Through June 30, 2032 Cardinal Health (NYSE:CAH) announced today that it has entered into a binding Letter of Intent to extend its existing distribution agreement with CVS Health through June 30, 2032, reflecting the…
benzinga.com 9 Health Care Stocks Whale Activity In Today’s Session This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity…- benzinga.com RBC Capital Initiates Coverage On Cardinal Health with Outperform Rating, Announces Price Target of $276 RBC Capital analyst Ryan Halsted initiates coverage on Cardinal Health (NYSE:CAH) with a Outperform rating and announces Price Target of $276.
- benzinga.com TD Cowen Maintains Buy on Cardinal Health, Raises Price Target to $280 TD Cowen analyst Charles Rhyee maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $275 to $280.
- benzinga.com JP Morgan Maintains Neutral on Cardinal Health, Raises Price Target to $260 JP Morgan analyst Lisa Gill maintains Cardinal Health (NYSE:CAH) with a Neutral and raises the price target from $215 to $260.
- benzinga.com Barclays Maintains Overweight on Cardinal Health, Raises Price Target to $275 Barclays analyst Glen Santangelo maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $258 to $275.
- benzinga.com Evercore ISI Group Maintains Outperform on Cardinal Health, Raises Price Target to $270 Evercore ISI Group analyst Elizabeth Anderson maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $265 to $270.
- benzinga.com Morgan Stanley Maintains Overweight on Cardinal Health, Raises Price Target to $265 Morgan Stanley analyst Erin Wright maintains Cardinal Health (NYSE:CAH) with a Overweight and raises the price target from $255 to $265.
benzinga.com Mizuho Maintains Outperform on Cardinal Health, Raises Price Target to $250 Mizuho analyst Steven Valiquette maintains Cardinal Health (NYSE:CAH) with a Outperform and raises the price target from $240 to $250.- benzinga.com UBS Maintains Buy on Cardinal Health, Raises Price Target to $280 UBS analyst Kevin Caliendo maintains Cardinal Health (NYSE:CAH) with a Buy and raises the price target from $274 to $280.